Search Results

Lauren M. Slosky About Dr. Lauren M. Lauren M.

Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232, USA 4 Peking University, China Hamm, Ph.D. is the Aileen M.

“We’re enhancing the powerful pain-relieving effects of opioids while limiting respiratory depression He is particularly excited by the novel application of PAMs in chronic and neuropathic pain models , Discovering breakthrough results in neuroma pain models via a spontaneous collaboration. Ben M Clements is a behavioral pharmacologist who uses in vitro and in vivo models to discover and characterize novel treatments for chronic pain and opioid use disorder.

Strategy: From Personal Pain to Scientific Purpose Dr. pain research at Hopkins and later an MD-PhD at Mount Sinai. His early exposure to TRPV1 channels and peripheral pain mechanisms with Dr. Pain became more than biology — it became a personal strategy. “Half the time, in pain, what works in vivo doesn’t translate to clinic.

Kathleen Caron About Kathleen M. Caron Kathleen M. Caron, Ph.D. is the Frederik L. Kathleen M. Caron on the web Lab Website Twitter Pubmed Google Scholar Orcid Enjoying the Dr.

Home → Flash News → Can we preserve opioid pain relief without the side effects? GPCR Podcast Can we preserve opioid pain relief without the side effects?

Biotech founder Ajay Yekkirala shares how AI, GPCRs, and bold questions are driving next-gen pain therapeutics breakthrough GPCR research career The inside story behind founding Blue Therapeutics and targeting supraspinal pain Woolf at Boston Children’s Hospital and Harvard Medical School, where he deepened his understanding of pain Driven by the opioid crisis and the lack of non-addictive pain treatments, Ajay co-founded Blue Therapeutics , a biotech startup focused on targeting supraspinal GPCRs for chronic pain.

published seminal papers where he used various approaches to describe the role of opioid receptors in pain Dr Gendron is co-director of the FRQS-funded Quebec Pain Research Network and the Editor-in-Chief in

. 🧠 Pain, inflammation, metabolism: the implications go far beyond signaling bias. 🔗 Read the full This could reshape how we understand CGRP-related physiology—and how we target it in drug design. 🧠 Pain

GPCR Title: Characterization of Novel Opioid-Neurotensin Bifunctional Ligands Designed to Target Pain interested in characterizing novel G protein-coupled receptors (GPCRs) ligands for the treatment of chronic pain

mechanisms of flavonoids in cancer using nuclear magnetic resonance spectroscopy (NMR) led to a Barry M.

of opioid receptors and is currently focusing on the pharmacology of cannabinoids in the context of pain

Nigel Bunnett at the NYU Pain Research Center as a postdoctoral researcher. focuses on investigating GPCR signaling and trafficking in the context of inflammation and chronic pain Next Steps Badr will continue focusing his research on GPCRs involved in pain and inflammation during Badr shared his passion for GPCR signalling and regulation, specifically in the context of pain and inflammation

signalling Date & Time Friday, November 3rd / 1:30 PM Abstract Coming Soon About Fabiola Ribeiro "Fabiola M.

characterization of the pharmacological properties of cannabinoids in conjunction with terpenes for pain

Time Thursday, November 2nd / 4:30 PM Keynote Talk Abstract Coming Soon About Kathleen Caron "Kathleen M.

Founder & Director Yamina Berchiche Get in touch Co-Founder Attila Foris Get in touch Board Member Anne M.

conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain

next career step took her to AstraZeneca as a postdoctoral trainee, where she studied animal models of pain

neurons), Vollum Institute Portland (visiting scientist with Ed McCleskey, sensory neuron properties); Pain

passion, I recently started a postdoctoral fellowship to study the role of GPCRs in the mechanisms of pain

Klein's lab where she helped to investigate the role of various ATP-sensitive potassium channels in pain

available for AGPCR 24 Attendees Authors & Affiliations "Tobias Langenhan, Nicole Scholz, Genevieve M.

I spent time running for the chair of International Affairs for the U-M Postdoctoral Association (UMPDA

But loss has a way of sharpening focus—friends lost to overdose brought the opioid epidemic into painful

Kathleen Caron " "Kathleen M. Caron, Ph.D. is the Frederik L.

Journey Today Meet the Leadership Founder & Director Yamina Berchiche Get in Touch Board Member Anne M.

Tina M. Iverson. I then pursued a postdoctoral research position under the mentorship of Dr.

conjugates to target GPCRs, with a focus on receptors relevant for treating osteoporosis, diabetes, and pain

Caron Keynote Lecture Kathleen M.